Literature DB >> 14705380

The continuum of GERD complications.

M Brian Fennerty1.   

Abstract

Complications of chronic gastroesophageal reflux disease (GERD) run the gamut from erosive esophagitis to esophageal cancer, but all are linked to repeated exposure of the esophagus to caustic gastric and duodenal acid. Progression from one complication to another is not clearly established across the GERD continuum, although there is a clear progression from the serious complication of Barrett's esophagus to esophageal adenocarcinoma. This review examines the range of complications that can arise from chronic GERD, underscoring the need to view heartburn as a symptom of a potentially serious condition.

Entities:  

Mesh:

Year:  2003        PMID: 14705380     DOI: 10.3949/ccjm.70.suppl_5.s33

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  9 in total

1.  Shedding light on the epidemiology of gastroesophageal reflux disease in India--a big step forward.

Authors:  Srinivas Gaddam; Prateek Sharma
Journal:  Indian J Gastroenterol       Date:  2011-07-23

2.  Does epilepsy influence the outcome of antireflux procedures in neurologically impaired children?

Authors:  A Goessler; A Huber-Zeyringer; M E Hoellwarth
Journal:  Pediatr Surg Int       Date:  2006-04-29       Impact factor: 1.827

3.  Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma.

Authors:  Silvana Papagerakis; Emily Bellile; Lisa A Peterson; Maria Pliakas; Katherine Balaskas; Sara Selman; David Hanauer; Jeremy M G Taylor; Sonia Duffy; Gregory Wolf
Journal:  Cancer Prev Res (Phila)       Date:  2014-12

4.  Night Work, Rotating Shift Work, and the Risk of Cancer in Japanese Men and Women: The JACC Study.

Authors:  Ahmed Arafa; Ehab S Eshak; Hiroyasu Iso; Isao Muraki; Akiko Tamakoshi
Journal:  J Epidemiol       Date:  2021-02-18       Impact factor: 3.211

5.  Long-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis.

Authors:  Thomas O Kovacs; James W Freston; Marian M Haber; Barbara Hunt; Stuart Atkinson; David A Peura
Journal:  Dig Dis Sci       Date:  2009-03-07       Impact factor: 3.199

Review 6.  Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease.

Authors:  J Pisegna; G Holtmann; C W Howden; P H Katelaris; P Sharma; S Spechler; G Triadafilopoulos; G Tytgat
Journal:  Aliment Pharmacol Ther       Date:  2004-12       Impact factor: 8.171

7.  Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan.

Authors:  Hideki Mizuno; Nobuyuki Matsuhashi; Masahiro Sakaguchi; Syuji Inoue; Koji Nakada; Kazuhide Higuchi; Ken Haruma; Takashi Joh
Journal:  J Clin Biochem Nutr       Date:  2015-10-07       Impact factor: 3.114

8.  Effects of Platycodin D on Reflux Esophagitis due to Modulation of Antioxidant Defense Systems.

Authors:  Su-Yeon Cho; Chang-Hyun Song; Ji-Eun Lee; Seong Hun Choi; Sae-Kwang Ku; Soo-Jin Park
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-26       Impact factor: 2.629

9.  Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study.

Authors:  Jae Ho Cho; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim; Dong Ho Lee
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.